Canada markets open in 8 hours 32 minutes

InnoCan Pharma Corporation (INNPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.41590.0000 (0.00%)
At close: 11:03AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.4159
Open0.4020
BidN/A x N/A
AskN/A x N/A
Day's Range0.4159 - 0.4159
52 Week Range0.3714 - 1.2706
Volume12,000
Avg. Volume3,133
Market Cap103.359M
Beta (5Y Monthly)3.65
PE Ratio (TTM)N/A
EPS (TTM)-0.0250
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Innocan Pharma Meets Pre-Clinical End-Point in Pilot Pain Study on Dogs Using LPT Liposome Technology

    6 dogs suffering from osteoarthritis and lameness demonstrated CBD concentrations 6 weeks after a single injectionPain and well-being scores improved following treatmentHerzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce positive partial results in a pilot pain study in dogs using the LPT CBD Liposomal Delivery Platform.Six dogs suffering from osteoarthriti

  • Newsfile

    Innocan Pharma Is Reaching Close to 100% CBD Bioavailability In a Dog Clinical Study For its Proprietary LPT CBD Liposomal Delivery Platform

    First results from a study on dogs showed close to 100% bioavailability of CBD using Innocan's LPT technologyThis is compared to 6.5-20% bioavailability in humans when administered orallyHerzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce results that approached 100% bioavailability following subcutaneous injection of its CBD proprietary LPT delivery system

  • Baystreet

    Stocks in play: InnoCan Pharma

    Announces that it has filed a new patent application entitled "compositions for treatment of hair loss", ...